The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

Duke-NUS researchers have identified that blocking specific proteins in immune cells can significantly reduce or reverse lung scarring. This discovery paves the way for novel treatments that could ...

"This work demonstrates the power of spatial transcriptomics combined with data science approaches in unraveling the molecular etiology of long COVID." The researchers note that the findings could ...

The most common type of lung fibrosis - scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school. But for many, the virus leaves behind a lasting impact—especially in ...

he most common type of lung fibrosis — scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Harish Narasimhan, University of Virginia (THE CONVERSATION) The long-term effects of ...